221 related articles for article (PubMed ID: 33243739)
41. Frequent coexistence of RAS mutations in RUNX1-mutated acute myeloid leukemia in Arab Asian children.
Al-Kzayer LF; Sakashita K; Al-Jadiry MF; Al-Hadad SA; Uyen le TN; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Hasan JG; Al-Abdullah HM; Inoshita T; Kamata M; Sughayer MA; Madanat FF; Koike K
Pediatr Blood Cancer; 2014 Nov; 61(11):1980-5. PubMed ID: 25066867
[TBL] [Abstract][Full Text] [Related]
42. Subtype-specific patterns of molecular mutations in acute myeloid leukemia.
Rose D; Haferlach T; Schnittger S; Perglerová K; Kern W; Haferlach C
Leukemia; 2017 Jan; 31(1):11-17. PubMed ID: 27285584
[TBL] [Abstract][Full Text] [Related]
43. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L
Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066
[TBL] [Abstract][Full Text] [Related]
44. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.
Thol F; Damm F; Lüdeking A; Winschel C; Wagner K; Morgan M; Yun H; Göhring G; Schlegelberger B; Hoelzer D; Lübbert M; Kanz L; Fiedler W; Kirchner H; Heil G; Krauter J; Ganser A; Heuser M
J Clin Oncol; 2011 Jul; 29(21):2889-96. PubMed ID: 21670448
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
46. RUNX1/CEBPA Mutation in Acute Myeloid Leukemia Promotes Hypermethylation and Indicates for Demethylation Therapy.
Romanova EI; Zubritskiy AV; Lioznova AV; Ogunleye AJ; Golotin VA; Guts AA; Lennartsson A; Demidov ON; Medvedeva YA
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232714
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Value of RUNX1 Mutations in AML: A Meta-Analysis.
Jalili M; Yaghmaie M; Ahmadvand M; Alimoghaddam K; Mousavi SA; Vaezi M; Ghavamzadeh A
Asian Pac J Cancer Prev; 2018 Feb; 19(2):325-329. PubMed ID: 29479958
[TBL] [Abstract][Full Text] [Related]
48. Investigations of the prognostic value of RUNX1 mutation in acute myeloid leukemia patients: Data from a real-world study.
Wan CL; Huang YH; Huang SM; Xu YL; Tan KW; Yan-Qiu ; Shen XD; Ge SS; Cao HY; Li YY; Liu SB; Qi JJ; Dai HP; Xue SL
Leuk Res; 2024 Apr; 139():107483. PubMed ID: 38493755
[TBL] [Abstract][Full Text] [Related]
49. RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia.
Bera R; Chiu MC; Huang YJ; Lin TH; Kuo MC; Shih LY
J Hematol Oncol; 2019 Oct; 12(1):104. PubMed ID: 31640815
[TBL] [Abstract][Full Text] [Related]
50. Distinct gene expression pattern of RUNX1 mutations coordinated by target repression and promoter hypermethylation in acute myeloid leukemia.
Li J; Jin W; Tan Y; Wang B; Wang X; Zhao M; Wang K
Front Med; 2022 Aug; 16(4):627-636. PubMed ID: 34958450
[TBL] [Abstract][Full Text] [Related]
51. [Comparision of Mutational Spectrum between Elderly and Young Adults with Acute Myeloid Leukemia Based on Next Generation Sequencing].
Wang WM; Li YF; Sun L; Jiang ZX; Wan DM; Ma J; Gan SL; Wang F; Cao WJ; Sun H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):12-17. PubMed ID: 32027246
[TBL] [Abstract][Full Text] [Related]
52. [Analysis of Genomic Landscape in Patients with Acute Myeloid Leukemia].
Wang SM; Zheng HJ; Tian Y; Zhang JM; Yao JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):797-801. PubMed ID: 32552938
[TBL] [Abstract][Full Text] [Related]
53. [Correlation between myeloperoxidase expression and gene alterations and prognosis in acute myeloid leukemia].
Dong XY; Li YL; Jiang L; Wu CY; Shang BJ; Zhang L; Cheng W; Zhu ZM
Zhonghua Xue Ye Xue Za Zhi; 2019 Jan; 40(1):40-45. PubMed ID: 30704227
[No Abstract] [Full Text] [Related]
54. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.
Renneville A; Boissel N; Nibourel O; Berthon C; Helevaut N; Gardin C; Cayuela JM; Hayette S; Reman O; Contentin N; Bordessoule D; Pautas C; Botton Sd; Revel Td; Terre C; Fenaux P; Thomas X; Castaigne S; Dombret H; Preudhomme C
Leukemia; 2012 Jun; 26(6):1247-54. PubMed ID: 22289988
[TBL] [Abstract][Full Text] [Related]
55. Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status.
Silva FP; Swagemakers SM; Erpelinck-Verschueren C; Wouters BJ; Delwel R; Vrieling H; van der Spek P; Valk PJ; Giphart-Gassler M
Blood; 2009 Oct; 114(14):3001-7. PubMed ID: 19666867
[TBL] [Abstract][Full Text] [Related]
56. High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.
Kao HW; Liang DC; Kuo MC; Wu JH; Dunn P; Wang PN; Lin TL; Shih YS; Liang ST; Lin TH; Lai CY; Lin CH; Shih LY
Oncotarget; 2015 Oct; 6(32):33217-25. PubMed ID: 26375248
[TBL] [Abstract][Full Text] [Related]
57. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
Schlenk RF; Döhner K; Krauter J; Fröhling S; Corbacioglu A; Bullinger L; Habdank M; Späth D; Morgan M; Benner A; Schlegelberger B; Heil G; Ganser A; Döhner H;
N Engl J Med; 2008 May; 358(18):1909-18. PubMed ID: 18450602
[TBL] [Abstract][Full Text] [Related]
58. [Analysis of induction efficacy and prognostic factors in FLT3-ITD positive acute myeloid leukemia in the real world].
Jia JS; Zhu HH; Gong LZ; Zhao T; Wang J; Jiang Q; Huang XJ; Jiang H
Zhonghua Xue Ye Xue Za Zhi; 2019 May; 40(5):398-403. PubMed ID: 31207705
[No Abstract] [Full Text] [Related]
59. [Frequency and clinical features of ASXL2 gene mutation in acute myeloid leukemia patients with AML1- ETO fusion gene positive].
Zhao JX; Chen XH; Li JL; Pan J; Tan YH; Xu ZF; Ren FG; Zhang YF; Xu J; Li MQ; Li J; Zhang N; Chang JM; Wang XJ; Wang HW
Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):676-81. PubMed ID: 27587249
[TBL] [Abstract][Full Text] [Related]
60. Importance of prognostic stratification via gene mutation analysis in elderly patients with acute myelogenous leukemia.
Fujiwara Y; Yamaguchi H; Yui S; Tokura T; Inai K; Onai D; Omori I; Marumo A; Yamanaka S; Sakaguchi M; Terada K; Nakagome S; Arai K; Kitano T; Okabe M; Okamoto M; Tamai H; Nakayama K; Tajika K; Wakita S; Inokuchi K
Int J Lab Hematol; 2019 Aug; 41(4):461-471. PubMed ID: 30970181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
